Skip to main content
See every side of every news story
Published • loading... • Updated

Halozyme slips as German court overturns injunction against Merck

Summary by Seeking Alpha
Halozyme (HALO) stock fell after a German court overturned an injunction blocking Merck's (MRK) injectable Keytruda. Read more here.

4 Articles

Lean Right

Merck (MSD) of the United States has seen its patent burden surrounding the immunotherapy drug ‘Keytruda Curex’ significantly reduced. This follows a complete victory in the U.S. patent invalidation trial against Halozyme Therapeutics. Alteogen’s subcutaneous (SC) injection technology is applied to Keytruda Curex. On the 18th (local time), the Patent Trial and Appeal Board (PTAB) under the U.S. Patent and Trademark Office (USPTO) [announced] tha…

占싱깍옙 占쏙옙크(MSD)占쏙옙 kit占쏙옙占 占쏙옙占쏙옙怜占(SC) 占쏙옙占쏙옙占 占싸곤옙 占쌀뤄옙占쌈곤옙 占쏙옙占싱담옙 특占쏙옙 占쏙옙占∽옙占 占싱깍옙占쏙옙 占쏙옙占싹울옙占쏙옙 占쏙옙占싱억옙 占싱곤옙占.占싱깍옙占쏙옙占쏙옙占쏙옙 占쌀뤄옙占쏙옙 특占썬가 占쏙옙占쏙옙占쏙옙占 占쏙옙효 占실담옙占 占쌨았곤옙 占쏙옙占싹울옙占쏙옙占쏙옙 占실매몌옙 占쏙옙占쏙옙 占쏙옙占쏙옙 占쏙옙...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

조선일보 broke the news on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal